Table S1 from Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL
Authors:
- Yi-Jiun SuYSYi-Jiun Su
- Anne Marijn KramerAKAnne Marijn Kramer
- Mark P. HamiltonMHMark P. Hamilton
- Neha AgarwalNANeha Agarwal
- Hrishikesh K. SrinageshHSHrishikesh K. Srinagesh
- John H. BairdJBJohn H. Baird
- Bita SahafBSBita Sahaf
- Adam KuoAKAdam Kuo
- Zachary J. EhlingerZEZachary J. Ehlinger
- Moksha H. DesaiMDMoksha H. Desai
- Skyler P. RietbergSRSkyler P. Rietberg
- Ramya TunuguntlaRTRamya Tunuguntla
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)